咪唑基

基本解释 (translations)

imidazolyl

与咪唑基相关的网络例句 [注：此内容来源于网络，仅供参考]

The compounds are represented by the structural Formula 1, Chemical formula should be inderted here as it appears on the abstract in paper form. a prodrug thereof, or any pharmaceutically acceptable salt, solvate, isomer or racemic mixture of the compound or said prodrug wherein R1 is heteroaryl, N-arylaminocarbonyl, N-heteroarylaminocarbonyl, benzimidazolyl or benzothiazolyl; R15 is present or not and if present is H, aryl, alkyl, arylalky or heteroarylalkyl; A is aryl, heteroaryl, cycloalkyl, cycloalkylidene, heterocycloalkylidene or heterocycloalkyl wherein said aryl, heteroaryl, cycloalkyl, cycloalkylidene, heterocycloalkylidene and heterocycloalkyl moieties may be substituted or unsubstituted; and B, L, X and R18 are defined herein.

所述化合物用结构式1表示，包括其前药或所述化合物或所述前药的任何药学上可接受的盐、溶剂合物、异构体或外消旋混合物，其中R 1 为杂芳基、N-芳基氨基羰基、N-杂芳基氨基羰基、苯并咪唑基或苯并噻唑基；R 15 存在或不存在，如果存在，则为H、芳基、烷基、芳基烷基或杂芳基烷基；A为芳基、杂芳基、环烷基、环烷叉基、杂环烷叉基或杂环烷基，其中所述芳基、杂芳基、环烷基、环烷叉基、杂环烷叉基和杂环烷基部分可被取代或未被取代；B、L、X和R 18 如说明书所定义。

New ruthenium benzylidene complexes benzylidene[1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-2-ylidene] [k~2-diphenylphosphinoacetato] monochlororuthenium (46), benzylidene[1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-2-ylidene][k~2-3-propionato]monochlororuthenium (47), benzylidene[1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-2-ylidene] [k~2-2-benzonato]monochlororuthenium (48) featured five-membered, flexible six-membered and rigidsix-membered chelating rings respectively are prepared by reactions of complex 41 withcorresponding sodium phosphino-carboxylates. It is confirmed by X-ray crystallographicanalysis that the coordination geometries of complexes 46 and 47 are distorted squarepyramids with phosphino-carboxylate ligands chelating to ruthenium, and the coordinationbetween ruthenium and benzylidene ligands are strengthened.

用二苯基瞵乙酸盐、二苯基膦丙酸盐、二苯基膦苯甲酸盐与钌卡宾配合物41反应合成了三个新的钌卡宾配合物：含五元膦-氧螯合环的1，3-二-(2，6-二甲苯基)-4，5-二氢咪唑基1-苯亚甲基--一氯合钌(46)、含六元柔性膦-氧螯合环的[1，3-二-(2，6-二甲苯基)-4，5-二氢咪唑基1-苯亚甲基--一氯合钌(47)及含六元刚性膦-氧螯合环的[1，3-二-(2，6-二甲苯基)-4，5-二氢咪唑基]-苯亚甲基--一氯合钌(48)。X射线单晶衍射分析证明，配合物46、47都为变形的四方锥构型，膦-氧与钌形成螯合配位，其中苯亚甲基与钌的配位得以加强。

Benzylidene[1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-2-ylidene]dichloro(2-methylpyridine)ruthenium (62), benzylidene[1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-2-ylidene] dichloro(2,4-dimethylpyridine)ruthen ium (63) introduce ortho substituted pyridine as dissociating ligand to weaken Ru-N bondand accelerate dissociation of pyridine derivative ligand through steric hindrance.

在钌卡宾配合物[1，3-二-(2，6-二甲苯基)-4，5-二氢咪唑基]-苯亚甲基-(2-甲基吡啶)-二氯合钌(62)，1，3-二-(2，6-二甲苯基)-4，5-二氢咪唑基1-苯亚甲基-(2，4-二甲基吡啶)-二氯合钌(63)中，邻位取代的吡啶作为解离配体，通过邻位基团的空间效应削弱钌-氮配位键，使配体更易解离，提高了催化剂的初活性。

One class is CAAX-mimetic compounds with an imidazolyl residue on one end and a carboxylic group on the other connected by benzodiazepine scaffold at different positions.

连有咪唑基的苯并二氮杂草化合物，以苯并二氮杂草-2-酮为分子骨架，7位连接含有咪唑基的侧链，1位或3位连接含羧基或酯基的侧链。此类化合物模拟了CAAX配体。

PBIOM or benzylimidazoleand CoP in chloroform solution were mixed to complex the imidazolyl residue of the ligands with the fifth coordination site of CoP under nitrogen atmosphere to get CoP complexes.

PBIOM或苄基咪唑中的咪唑基与CoP在溶液中配位，得到的CoP-PBIOM或CoP-BIm络合物具有快速、可逆的氧结合特性。

The behaviors of supramolecular self-assembly of cabboxyl porphyrin-anthraquinone systems, carboxyl porphyrin zinc-copper systems, porphyrinatozinc-imidazolyl tailed porphyrinatomanganese systems, porphyrinatozinc-anthraquinone hybrids/imidazolyl tailed porphyrinatomanganese systems and porphyrinatozinc-fluorescein hybrids/imidazolyl tailed porphyrinatomanganese systems driven by hydrogen-bonding or coordination-bonding have been studied.

设计、合成了多种新型羧基卟啉、卟啉-蒽醌二元化合物和卟啉-荧光素二元化合物，研究了氢键或配位键驱动的羧基卟啉-蒽醌、羧基卟啉锌-羧基卟啉铜、锌卟啉-咪唑基尾式卟啉锰二元超分子，卟啉-蒽醌二元化合物与咪唑基尾式卟啉锰三元超分子的构建和光诱导电子转移性质。

N -(4-vinyl)benzylimidazole and its copolymer with octyl methacrylatewere synthesized and characterized,and oxygen—binding properties of cabaltporphyrincomplexes with imdazole ligands were studied.

研究了 N -(4-乙烯基)苄基咪唑单体及其与甲基丙烯酸辛酯共聚物的合成与表征，以及咪唑基有机或聚合物配位体与钴卟啉络合物的氧结合性能。

Their structures were characterized by IR, 1H NMR, of which 4-chloro- 2-methyl-7-(2-bromoethoxy) isoflavone, 2, 4\'-dimethyl-7-(2-bromo-ethoxy)isoflavone and 2-methyl-7-(2-bromoethoxy) isoflavone are rarely reported so far.4\'-chloro-2-methyl-7-(3-bromopropoxy)isoflavone, 2, 4\'-dimethyl-7-(3-bromo- propoxy) isoflavone, 2-methyl-7-(3-bromopropoxy) isoflavone, 4\'-methoxy-2-methyl-7-(3-bromopropoxy) isoflavone and 4\'-hydroxy-2-methyl-7-(3-bromopropoxy) isoflavone were gained by reacting 7-hydroxy-2-methyl isoflavone derivatives with 1, 3-dibromo- propane, respectively.

第三章(来源：73ABC论文网www.abclunwen.com)在丙酮溶液中以K_2CO_3为碱，使溴乙氧基异黄酮和溴丙氧基异黄酮与咪唑偶合，以较高的产率合成出10种目标化合物：2-甲基-4′-氯-7-2-(1-咪唑基乙氧基异黄酮、2，4′-二甲基-7-2-(1-咪唑基乙氧基异黄酮、2-甲基-7-2-(1-咪唑基乙氧基异黄酮、2-甲基-4′-甲氧基-7-2-(1-咪唑基乙氧基异黄酮、2-甲基-4′-羟基-7-2-(1-咪唑基乙氧基异黄酮、2-甲基-4′-氯-7-3-(1-咪唑基丙氧基异黄酮、2，4′-二甲基-7-3-(1-咪唑基丙氧基异黄酮、2-甲基-7-3-(1-咪唑基丙氧基异黄酮、2-甲基-4′-甲氧基-7-3-(1-咪唑基丙氧基异黄酮、2-甲基-4′-羟基-7-3-(1-咪唑基丙氧基异黄酮，经IR、~1H NMR、~(13)C NMR、元素分析等对其结构进行了表征，10种目标产物均未见文(来源：ABC论文cccccc网www.abclunwen.com)献报道。

As for the ester exchange reaction on phosphorus, it was found that N-phosphoryl histidine the fastest one among all of the N-phosphoryl aminoacids. The results studied by MNDO method indicate that due to theparticipation of imidazole group, the formation of hexa-coordinatephosphorus intermediate made the iso-propoxyl which is opposite toimidazole group more active than the other ones and much easier to leave.When iso-propoxyl left, a new penta-coordinate phosphorus intermediate wasformed, and it is sterically favorable to be attacked by an alcohol from theopposite direction of imidazole.

对于磷上酯交换反应，实验中发现N-磷酰组氨酸反应速度明显高于其它N-磷酰氨基酸，理论研究表明，侧键咪唑基参与下六配位磷中间体形成后，位于咪唑基对面的异丙氧基反应活性大大提高，即从咪唑基的对面位置发生异丙氧基的离去和另一分子醇的进攻，在能量上和空间上都是有利的。N-磷酰丝氨酸的磷上酯交换反应有着类似的特点。

A convenient method to synthesize three kinds of novel 2-(2-hydroxyphenyl) benzimidazole in order to improve the solubilities of the fluorophores with substituent of carboxyl, ester and double-bond which are aimed for determining the sulphydryl group was reported.

合成了N-{3-(2-苯并咪唑基)-4-羟基苯基}马来酰亚胺酸， N-{3-(2-苯并咪唑基)-4-乙酸酯基苯基}和马来酰亚胺N-{3-(2-苯并咪唑基)-4-羟基苯基}马来酰亚胺，在基本荧光发射团上分别引入了羧酸基；酯基；双键活性基团。

与咪唑基相关的网络解释 [注：此内容来源于网络，仅供参考]

benzimidazole：苯并咪唑

主营产品及业务:三唑、咪唑系列:1,2,3-苯骈三氮唑(苯并三氮唑)、甲基苯骈三氮唑、甲基苯骈三氮唑钠盐、苯骈三氮唑钠(BTA-S)咪唑系列:咪唑(Imidazole)、2-甲基咪唑( 2-Methylimidazole)、2-乙基咪唑(2-Ethylimidazole)、苯并咪唑(Benzimidazole)、2-巯基苯并咪唑

benzimidazole：苯并咪唑,间(二)氮茚

benziloyl | 二苯乙醇酰基 | benzimidazole | 苯并咪唑,间(二)氮茚 | benzimide | 苯甲亚胺

5-Nitro benzimidazole：5-硝基苯并咪唑

5-氰吲哚 5-cyanoindole | 5-硝基苯并咪唑 5-Nitro benzimidazole | 5-硝基间苯二甲酸 5-Nitroisophthalic acid

1-Ethyl-2-Mercapto benzimidazole：1-乙基-2 巯基苯噻唑

9,10-二溴蒽 9,10- dibromo anthracene | 1-乙基-2巯基苯噻唑 1-Ethyl-2-Mercapto benzimidazole | 5-硝基苯并咪唑 5-Nitro benzimidazole

M-nitro benzoic acid：安息香酸 , 间硝基苯甲酸

4-nitrobenzoic acid 对硝基苯甲酸 | M-nitro benzoic acid 安息香酸 , 间硝基苯甲酸 | 5 or 6 nitrobenzoimidazole 5或6硝基苯甲酸咪唑

5-cyano indole：5-氰基吲哚

5-氰基吲哚 5-cyano indole | 5-氰吲哚 5-cyanoindole | 5-硝基苯并咪唑 5-Nitro benzimidazole

imidazolyl：咪唑基

咪唑啉基;二氢咪唑基 imidazolinyl | 咪唑基 imidazolyl | 亚胺基 imido

stearic imidazoline：羟乙基硬脂基咪唑啉

羟乙基硬脂酰基单异丙醇胺 hydroxyethyl stearamide-MIPA | 羟乙基硬脂基咪唑啉 stearic imidazoline | 羟乙基乙二胺三乙酸三钠 trisodium hydroxy ethyl ethylenediamine triacetate

thienyl：噻吩基

选自吡嗪基、吡唑基、哒嗪基、吡啶基、嘧啶基、吡咯 基、四唑基、呋喃基、咪唑基、三嗪基、吡喃基、噻唑基、噻吩基(thienyl)、 噻吩基(thiophenyl)、三唑基、唑基、异唑基、噻唑基、二唑基、 吲哚基、喹啉基、异喹啉基、苯并咪唑基及苯并唑基的杂芳基,

hydroxyimjdazole propionic acid：羟(基)咪唑丙酸

94.homosomal aberration 染色体内畸变 | 96.hydroxyimjdazole propionic acid 羟(基)咪唑丙酸 | 97.hyperacute rejection 超急排斥